These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy. Lowe G; Woodward M; Vessey M; Rumley A; Gough P; Daly E Thromb Haemost; 2000 Apr; 83(4):530-5. PubMed ID: 10780311 [TBL] [Abstract][Full Text] [Related]
6. Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium. Nelson SM; Greer IA Obstet Gynecol Clin North Am; 2006 Sep; 33(3):413-27. PubMed ID: 16962918 [TBL] [Abstract][Full Text] [Related]
7. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. De Stefano V; Martinelli I; Rossi E; Battaglioli T; Za T; Mannuccio Mannucci P; Leone G Br J Haematol; 2006 Nov; 135(3):386-91. PubMed ID: 16984390 [TBL] [Abstract][Full Text] [Related]
8. Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy. Waselenko JK; Nace MC; Alving B Semin Thromb Hemost; 1998; 24 Suppl 1():33-9. PubMed ID: 9840690 [TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism associated with pregnancy and hormonal therapy. Jacobsen AF; Sandset PM Best Pract Res Clin Haematol; 2012 Sep; 25(3):319-32. PubMed ID: 22959548 [TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M; Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology and risk factors of venous thromboembolism. Ageno W; Squizzato A; Garcia D; Imberti D Semin Thromb Hemost; 2006 Oct; 32(7):651-8. PubMed ID: 17024592 [TBL] [Abstract][Full Text] [Related]
13. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy. DeSancho MT; Dorff T; Rand JH Blood Coagul Fibrinolysis; 2010 Sep; 21(6):534-8. PubMed ID: 20581664 [TBL] [Abstract][Full Text] [Related]
14. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET). Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141 [TBL] [Abstract][Full Text] [Related]
15. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill? Mills A; Wilkinson C; Fotherby K Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763 [TBL] [Abstract][Full Text] [Related]
16. [Effect of hormonal changes in women on hemostasis]. Malý J; Dulícek P Vnitr Lek; 2002 Dec; 48(12):1169-73. PubMed ID: 12642936 [TBL] [Abstract][Full Text] [Related]
17. [Pregnancy-associated venous thrombosis in women with hereditary heterozygous factor V Leiden and/or factor II gene mutations]. Samama MM; Rached RA; Conard J; Horellou MH; Elalamy I Bull Acad Natl Med; 2004; 188(8):1377-93; discussion 1393-6. PubMed ID: 15918665 [TBL] [Abstract][Full Text] [Related]
18. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration. Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY; Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339 [TBL] [Abstract][Full Text] [Related]
19. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?]. Plu-Bureau G; Horellou MH; Gompel A; Conard J Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163 [TBL] [Abstract][Full Text] [Related]